Wayne has repeatedly indicated possible revenue of $5b with the company value being multiples of this. I believe he has mentioned 3-5 times revenue in the past. This would give a company valuation in a few years of $20b.
The last raise of $28m (aud) gave 14% of the company therefore providing a valuation of $200m.
Given this disconnect, is it possible for future funding to be at a premium to the existing shareprice at the time capital is raised or at a minimum substantially more than the $200m?
Has the Nasdaq capital raise pricing been discussed at board level and would it be expected to be above $500m valuation?
- Forums
- ASX - By Stock
- AVR
- AGM questions to be submitted to the CEO
AVR
anteris technologies global corp.
Add to My Watchlist
6.09%
!
$6.27

AGM questions to be submitted to the CEO, page-70
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M |
Open | High | Low | Value | Volume |
$5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1000 | 6.000 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
6.270 | 200 | 1 |
6.300 | 463 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online